Novem Pharma

Hyphens Pharma's growth mindset catches the eye of CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

Hyphens Pharma's growth mindset catches the eye of CGS-CIMB

CGS-CIMB is initiating coverage on Hyphens Pharma with an ‘add’ call and target price of 36 cents.
Hyphens Pharma acquires Novem group of companies for $16.3 mil - THE EDGE SINGAPORE

M&A

Hyphens Pharma acquires Novem group of companies for $16.3 mil

The acquisition will be earnings accretive for Hyphens Pharma.
×